Cargando…

Prognostic Factors of MS Conversion in Optic Neuritis

Investigators from Children's Hospital Aschaffenburg, Germany; University of Manchester, Manchester, United Kingdom; University Children's Hospital Tübingen, Tübingen, Germany; and other international centers studied prognostic factors in optic neuritis.

Detalles Bibliográficos
Autores principales:	Fajardo, Marytery, Rubin, Jennifer P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pediatric Neurology Briefs Publishers 2015
Materias:	Demyelinating Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747311/ https://www.ncbi.nlm.nih.gov/pubmed/26933585 http://dx.doi.org/10.15844/pedneurbriefs-29-6-5

Ejemplares similares

MRI to Discriminate Pediatric MS from ADEM
por: Rubin, Jennifer P.
Publicado: (2015)

Relation of Posterior Cerebellar Volume to Cognition in MS
por: Millichap, J. Gordon
Publicado: (2015)

Axonal Damage in Pediatric Multiple Sclerosis
por: Kuntz, Nancy L.
Publicado: (2015)

Plasma Exchange for Treatment of Refractory Demyelination
por: Cronin, Michael, et al.
Publicado: (2020)

Quality of Life in Multiple Sclerosis
por: Williams, Mitchell T., et al.
Publicado: (2020)

Understanding the Spectrum of SLC2A1-Associated Disorders
por: Fajardo, Marytery, et al.
Publicado: (2017)

How to choose initial treatment in multiple sclerosis patients: a case-based approach
por: Apóstolos, Samira Luisa Pereira, et al.
Publicado: (2022)

A critical review and update on autoimmune encephalitis: understanding the alphabet soup
por: Simabukuro, Mateus Mistieri, et al.
Publicado: (2022)

Challenges and insights in immunization in patients with demyelinating diseases: a bench-to-bedside and evidence-based review
por: Silva, Guilherme Diogo, et al.
Publicado: (2022)

Differential diagnosis of demyelinating diseases: what's new?
por: Gomes, Ana Beatriz Ayroza Galvão Ribeiro, et al.
Publicado: (2022)

Insights into the Mechanisms That May Clarify Obesity as a Risk Factor for Multiple Sclerosis
por: Huitema, Marije J. D., et al.
Publicado: (2018)

Alemtuzumab for Multiple Sclerosis
por: Willis, Mark D., et al.
Publicado: (2016)

Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices
por: Chou, I-Jun, et al.
Publicado: (2016)

Optic Neuritis
por: Dooley, Mary Caitlin, et al.
Publicado: (2010)

Optic Neuritis
Publicado: (1890)

Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin
por: Sühs, Kurt-Wolfram, et al.
Publicado: (2016)

The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis
por: Tornic, Jure, et al.
Publicado: (2018)

Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations
por: Kalb, Rosalind, et al.
Publicado: (2019)

Caregiver Burden in Multiple Sclerosis: Recent Trends and Future Directions
por: Maguire, Rebecca, et al.
Publicado: (2020)

Cognitive Dysfunction in the Early Stages of Multiple Sclerosis—How Much and How Important?
por: Oset, Magdalena, et al.
Publicado: (2020)

Telehealth in Multiple Sclerosis Clinical Care and Research
por: Xiang, Xinran Maria, et al.
Publicado: (2021)

Multiple Sclerosis Management During the COVID-19 Pandemic
por: Hollen, Chris, et al.
Publicado: (2022)

Bruton’s Tyrosine Kinase Inhibition in Multiple Sclerosis
por: Schneider, Raphael, et al.
Publicado: (2022)

A 10-Year Single-Center Study of the Clinical Characteristics of Optic Neuritis-Related NMOSD, MS, and Double Seronegative Optic Neuritis, Together with Factors Predicting Visual Outcomes
por: Kemchoknatee, Parinee, et al.
Publicado: (2023)

Permeability of the blood–brain barrier predicts conversion from optic neuritis to multiple sclerosis
por: Cramer, Stig P., et al.
Publicado: (2015)

Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS
Publicado: (2018)

Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS
por: You, Yuyi, et al.
Publicado: (2017)

Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritis
por: You, Yuyi, et al.
Publicado: (2020)

Management of optic neuritis
por: Menon, Vimla, et al.
Publicado: (2011)

Optic Neuritis in Chlorosis
Publicado: (1905)

Optic Neuritis in Chlorosis
Publicado: (1904)

Typical optic neuritis?
por: Matalia, Jyoti, et al.
Publicado: (2018)

Erythropoietin for Optic Neuritis
por: Foroozan, Rod
Publicado: (2019)

MS optic neuritis-induced long-term structural changes within the visual pathway
por: Pawlitzki, Marc, et al.
Publicado: (2020)

Risk Factors for Idiopathic Optic Neuritis Recurrence
por: Du, Yi, et al.
Publicado: (2014)

Optic Neuritis in Typhoid Fever
Publicado: (1897)

Optic Neuritis (Retrobulbar and Papillary)
por: Paton, Leslie
Publicado: (1937)

Time is tissue in optic neuritis
por: Dalmau, Josep
Publicado: (2019)

Uveitis, optic neuritis and MOG
por: Gupta, Pranjal, et al.
Publicado: (2020)

Rodent Models of Optic Neuritis
por: Redler, Yael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hee2hs33avg570f52cfcgdnu06